350 likes | 591 Views
Slide 1. Presented By Jan Buckner at 2014 ASCO Annual Meeting. Slide 2. Presented By Jan Buckner at 2014 ASCO Annual Meeting. No Disclosures. Presented By Jan Buckner at 2014 ASCO Annual Meeting. Responses to Chemotherapy in Recurrent Low-grade Glioma Patients.
E N D
Slide 1 Presented By Jan Buckner at 2014 ASCO Annual Meeting
Slide 2 Presented By Jan Buckner at 2014 ASCO Annual Meeting
No Disclosures Presented By Jan Buckner at 2014 ASCO Annual Meeting
Responses to Chemotherapy in Recurrent Low-grade Glioma Patients Presented By Jan Buckner at 2014 ASCO Annual Meeting
PCV for newly diagnosed <br />Grade 2 O/OA Presented By Jan Buckner at 2014 ASCO Annual Meeting
R9802 SCHEMA Presented By Jan Buckner at 2014 ASCO Annual Meeting
Key Eligibility Criteria Presented By Jan Buckner at 2014 ASCO Annual Meeting
Pretreatment Patient Characteristics<br />Demographic Factors Presented By Jan Buckner at 2014 ASCO Annual Meeting
Pretreatment Patient Characteristics<br />Functional Status Presented By Jan Buckner at 2014 ASCO Annual Meeting
Pretreatment Patient Characteristics<br />Surgery and Histology Presented By Jan Buckner at 2014 ASCO Annual Meeting
Data Maturity Presented By Jan Buckner at 2014 ASCO Annual Meeting
Slide 12 Presented By Jan Buckner at 2014 ASCO Annual Meeting
ASCO 2014: Progression-Free Survival Presented By Jan Buckner at 2014 ASCO Annual Meeting
Progression-Free Survival<br />ASCO 2014 Presented By Jan Buckner at 2014 ASCO Annual Meeting
Slide 15 Presented By Jan Buckner at 2014 ASCO Annual Meeting
ASCO 2014: Overall Survival Presented By Jan Buckner at 2014 ASCO Annual Meeting
Overall Survival<br />ASCO 2014 Presented By Jan Buckner at 2014 ASCO Annual Meeting
Salvage Treatment Presented By Jan Buckner at 2014 ASCO Annual Meeting
Cox Proportional Hazards Model for Progression Free Survival <br />(n=251) Presented By Jan Buckner at 2014 ASCO Annual Meeting
Cox Proportional Hazards Model for Overall Survival <br />(n=251) Presented By Jan Buckner at 2014 ASCO Annual Meeting
Constitutional Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting
Hematologic Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting
Gastrointestinal Tract Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting
Late Radiotherapy Toxicity Presented By Jan Buckner at 2014 ASCO Annual Meeting
Categorical Change in MMSE Score by Treatment Arm Presented By Jan Buckner at 2014 ASCO Annual Meeting
Conclusions (Survival)<br /> Presented By Jan Buckner at 2014 ASCO Annual Meeting
Conclusions (Prognostic Variables) Presented By Jan Buckner at 2014 ASCO Annual Meeting
Conclusions (Toxicity) Presented By Jan Buckner at 2014 ASCO Annual Meeting
Conclusions (Trial Conduct) Presented By Jan Buckner at 2014 ASCO Annual Meeting
Future Plans Presented By Jan Buckner at 2014 ASCO Annual Meeting
Acknowledgements Presented By Jan Buckner at 2014 ASCO Annual Meeting
Slide 32 Presented By Jan Buckner at 2014 ASCO Annual Meeting
Back Up Slides Presented By Jan Buckner at 2014 ASCO Annual Meeting
Radiotherapy Review Presented By Jan Buckner at 2014 ASCO Annual Meeting
Chemotherapy Review Presented By Jan Buckner at 2014 ASCO Annual Meeting